Does low luteinizing hormone with low free testosterone indicate upstream pituitary-gonadal under-signaling?

In men, testosterone production is tightly regulated by the hypothalamic-pituitary-gonadal (HPG) axis. When this regulatory loop is disrupted, it manifests as specific biochemical patterns that pinpoint the exact anatomical source of the dysfunction.

Mechanistic pathways of under-signaling

• Receptor-level signaling: Luteinizing hormone (LH) is the primary driver of testicular steroidogenesis. It binds to LH receptors (LHCGR) on Leydig cells, activating G-protein-coupled adenylyl cyclase, raising intracellular cAMP, and mobilizing protein kinase A (PKA). Low circulating LH levels blunt this signaling cascade.
• Rate-limiting transport failure: The impairment of the cAMP/PKA pathway directly downregulates the expression and phosphorylation of steroidogenic acute regulatory (StAR) protein. Because StAR is the rate-limiting transporter of cholesterol across the mitochondrial membrane, its depletion halts downstream enzymatic conversion (including CYP11A1 and CYP17A1 pathways), suppressing testicular testosterone production.

Clinical implications and diagnostic mapping

• Secondary hypogonadism presentation: In primary testicular failure, low testosterone triggers a compensatory rise in gonadotropins. Conversely, when low free and bioavailable testosterone levels co-occur with low or "inappropriately normal" LH, it establishes a diagnosis of secondary (hypogonadotropic) hypogonadism.
• Upstream localization: This biochemical profile confirms that the Leydig cells are functional but lack the upstream pituitary signals required to initiate steroidogenesis, indicating hypothalamic or pituitary hypofunction and prompting further diagnostic workups such as prolactin measurement or pituitary MRI.

Bottom line

• Concomitant low LH and low free/bioavailable testosterone biochemically define secondary hypogonadism, demonstrating that upstream hypothalamic-pituitary under-signaling directly suppresses StAR-mediated cholesterol transport and impairs testicular testosterone synthesis.